Chlamydiaphage φCPG1 Capsid Protein Vp1 Inhibits Chlamydia trachomatis Growth via the Mitogen-Activated Protein Kinase Pathway.

PubWeight™: 0.79‹?›

🔗 View Article (PMID 27089359)

Published in Viruses on April 14, 2016

Authors

Yuanli Guo1, Rui Guo2, Quan Zhou3, Changgui Sun4, Xinmei Zhang5, Yuanjun Liu6, Quanzhong Liu7

Author Affiliations

1: Dermatology and Venereology Department, Tianjin Medical University General Hospital, No. 154 Anshan Road, Heping District, Tianjin 300052, China. lvninle@sina.com.
2: Dermatology and Venereology Department, Tianjin Medical University General Hospital, No. 154 Anshan Road, Heping District, Tianjin 300052, China. 13902052977@163.com.
3: Dermatology and Venereology Department, Tianjin Medical University General Hospital, No. 154 Anshan Road, Heping District, Tianjin 300052, China. peter-pf.liu@cn.ey.com.
4: Dermatology and Venereology Department, Tianjin Medical University General Hospital, No. 154 Anshan Road, Heping District, Tianjin 300052, China. 2008021327@tmu.edu.cn.
5: Dermatology and Venereology Department, Tianjin Medical University General Hospital, No. 154 Anshan Road, Heping District, Tianjin 300052, China. hongheifeiying@sina.com.
6: Dermatology and Venereology Department, Tianjin Medical University General Hospital, No. 154 Anshan Road, Heping District, Tianjin 300052, China. liuyuanjun1980@163.com.
7: Dermatology and Venereology Department, Tianjin Medical University General Hospital, No. 154 Anshan Road, Heping District, Tianjin 300052, China. liuquanzhong@medmail.com.cn.

Articles cited by this

Genome sequences of Chlamydia trachomatis MoPn and Chlamydia pneumoniae AR39. Nucleic Acids Res (2000) 8.69

A PCR primer bank for quantitative gene expression analysis. Nucleic Acids Res (2003) 6.76

Population-based study of chlamydial infection in China: a hidden epidemic. JAMA (2003) 5.40

Phage therapy in clinical practice: treatment of human infections. Curr Pharm Biotechnol (2010) 2.51

Intracellular interleukin-1alpha mediates interleukin-8 production induced by Chlamydia trachomatis infection via a mechanism independent of type I interleukin-1 receptor. Infect Immun (2007) 1.37

Molecular characterization of a bacteriophage (Chp2) from Chlamydia psittaci. J Virol (2000) 1.34

ERK2 but not ERK1 plays a key role in hepatocyte replication: an RNAi-mediated ERK2 knockdown approach in wild-type and ERK1 null hepatocytes. Hepatology (2007) 1.26

Microvirus of chlamydia psittaci strain guinea pig inclusion conjunctivitis: isolation and molecular characterization. Microbiology (2000) 1.22

Bacteriophage therapy: a potential solution for the antibiotic resistance crisis. J Infect Dev Ctries (2014) 1.11

Development status and future prospects for a vaccine against Chlamydia trachomatis infection. Vaccine (2013) 1.04

Nod1, but not the ASC inflammasome, contributes to induction of IL-1β secretion in human trophoblasts after sensing of Chlamydia trachomatis. Mucosal Immunol (2012) 0.99

Significant reduction in inflammatory response in the macaque model of chlamydial pelvic inflammatory disease with azithromycin treatment. J Infect Dis (2005) 0.97

Chlamydia bacteriophages. Arch Microbiol (2013) 0.85

Persistent Chlamydia trachomatis infection of HeLa cells mediates apoptosis resistance through a Chlamydia protease-like activity factor-independent mechanism and induces high mobility group box 1 release. Infect Immun (2011) 0.85

Azithromycin treatment modulates the extracellular signal-regulated kinase mediated pathway and inhibits inflammatory cytokines and chemokines in epithelial cells from infertile women with recurrent Chlamydia trachomatis infection. DNA Cell Biol (2011) 0.80

[Induction of IL-8 by Chlamydia trachomatis through MAPK pathway rather than NF-kappaB pathway]. Zhong Nan Da Xue Xue Bao Yi Xue Ban (2010) 0.80

2010 European guideline for Chlamydia trachomatis infections: recommending partner notification look-back periods. Int J STD AIDS (2011) 0.79